US Stock MarketDetailed Quotes

Mirum Pharmaceuticals (MIRM)

Watchlist
  • 91.490
  • -0.460-0.50%
Close Apr 24 16:00 ET
  • 91.490
  • 0.0000.00%
Post 20:01 ET
5.58BMarket Cap-194.66P/E (TTM)

Mirum Pharmaceuticals (MIRM) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Total revenue
54.74%521.31M
49.81%148.93M
47.17%133.01M
64.09%127.79M
61.20%111.59M
80.76%336.89M
42.93%99.41M
89.37%90.38M
107.68%77.88M
119.07%69.22M
Operating revenue
54.74%521.31M
49.81%148.93M
47.17%133.01M
64.09%127.79M
61.20%111.59M
80.76%336.89M
42.93%99.41M
89.37%90.38M
107.68%77.88M
119.07%69.22M
Cost of revenue
22.78%100.24M
24.07%28.26M
22.74%25.54M
15.79%23.42M
29.10%23.02M
73.56%81.64M
-8.95%22.78M
103.42%20.81M
196.93%20.23M
258.10%17.83M
Gross profit
64.97%421.07M
57.46%120.67M
54.48%107.47M
81.04%104.36M
72.34%88.57M
83.19%255.25M
72.08%76.63M
85.54%69.57M
87.87%57.65M
93.07%51.39M
Operating expense
29.27%443.21M
24.17%125.24M
27.49%104.87M
33.55%109.35M
33.25%103.75M
37.97%342.85M
30.78%100.86M
31.30%82.26M
48.99%81.88M
44.81%77.86M
Selling and administrative expenses
27.10%257.03M
30.44%74.13M
22.48%61.91M
28.61%63.29M
26.44%57.71M
38.62%202.22M
23.05%56.83M
38.37%50.55M
49.35%49.21M
51.02%45.64M
Research and development costs
32.39%186.18M
16.08%51.11M
35.48%42.96M
41.00%46.07M
42.90%46.04M
37.05%140.63M
42.32%44.03M
21.42%31.71M
48.45%32.67M
36.84%32.22M
Operating profit
74.73%-22.14M
81.15%-4.57M
120.52%2.6M
79.41%-4.99M
42.64%-15.18M
19.74%-87.61M
25.67%-24.22M
49.56%-12.68M
0.17%-24.23M
2.50%-26.47M
Net non-operating interest income expense
-220.23%-1.66M
52.53%-178K
-203.42%-355K
-569.88%-556K
-1,123.21%-573K
62.12%-519K
-276.89%-375K
-124.02%-117K
16.16%-83K
102.84%56K
Non-operating interest income
-7.72%12.73M
6.74%3.42M
-6.28%3.25M
-12.99%3.03M
-16.79%3.02M
0.41%13.79M
-15.13%3.2M
-14.58%3.47M
-3.89%3.49M
59.90%3.63M
Non-operating interest expense
0.55%14.39M
0.53%3.6M
0.56%3.61M
0.56%3.59M
0.53%3.6M
-5.26%14.31M
0.45%3.58M
0.34%3.59M
-4.21%3.57M
-15.68%3.58M
Other net income (expense)
95.47%2.37M
-194.37%-218K
136.34%395K
-72.44%86K
19.98%2.11M
102.34%1.21M
107.55%231K
-182.22%-1.09M
100.63%312K
316.65%1.76M
Special income (charges)
--0
----
----
----
----
--0
--0
--0
--0
----
Other non- operating income (expenses)
95.47%2.37M
-194.37%-218K
136.34%395K
-72.44%86K
19.98%2.11M
142.95%1.21M
107.55%231K
-182.22%-1.09M
213.87%312K
316.65%1.76M
Income before tax
75.35%-21.43M
79.63%-4.96M
119.03%2.64M
77.26%-5.46M
44.64%-13.65M
46.49%-86.91M
31.24%-24.37M
40.49%-13.89M
67.44%-24M
17.62%-24.66M
Income tax
87.96%1.94M
233.16%767K
-175.50%-262K
-36.69%402K
64.90%1.03M
3.94%1.03M
-356.00%-576K
39.36%347K
100.95%635K
210.45%624K
Net income
73.43%-23.36M
75.91%-5.73M
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
Net income continuous Operations
73.43%-23.36M
75.91%-5.73M
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
Minority interest income
Net income attributable to the parent company
73.43%-23.36M
75.91%-5.73M
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
73.43%-23.36M
75.91%-5.73M
120.41%2.91M
76.21%-5.86M
41.94%-14.68M
46.18%-87.94M
33.28%-23.79M
39.65%-14.24M
66.72%-24.64M
16.10%-25.28M
Basic earnings per share
74.59%-0.47
77.57%-0.1104
120.00%0.06
76.92%-0.12
44.44%-0.3
53.75%-1.85
30.63%-0.4922
47.37%-0.3
73.20%-0.52
32.50%-0.54
Diluted earnings per share
74.59%-0.47
77.57%-0.1104
116.67%0.05
76.92%-0.12
44.44%-0.3
53.75%-1.85
30.63%-0.4922
47.37%-0.3
73.20%-0.52
32.50%-0.54
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Total revenue 54.74%521.31M49.81%148.93M47.17%133.01M64.09%127.79M61.20%111.59M80.76%336.89M42.93%99.41M89.37%90.38M107.68%77.88M119.07%69.22M
Operating revenue 54.74%521.31M49.81%148.93M47.17%133.01M64.09%127.79M61.20%111.59M80.76%336.89M42.93%99.41M89.37%90.38M107.68%77.88M119.07%69.22M
Cost of revenue 22.78%100.24M24.07%28.26M22.74%25.54M15.79%23.42M29.10%23.02M73.56%81.64M-8.95%22.78M103.42%20.81M196.93%20.23M258.10%17.83M
Gross profit 64.97%421.07M57.46%120.67M54.48%107.47M81.04%104.36M72.34%88.57M83.19%255.25M72.08%76.63M85.54%69.57M87.87%57.65M93.07%51.39M
Operating expense 29.27%443.21M24.17%125.24M27.49%104.87M33.55%109.35M33.25%103.75M37.97%342.85M30.78%100.86M31.30%82.26M48.99%81.88M44.81%77.86M
Selling and administrative expenses 27.10%257.03M30.44%74.13M22.48%61.91M28.61%63.29M26.44%57.71M38.62%202.22M23.05%56.83M38.37%50.55M49.35%49.21M51.02%45.64M
Research and development costs 32.39%186.18M16.08%51.11M35.48%42.96M41.00%46.07M42.90%46.04M37.05%140.63M42.32%44.03M21.42%31.71M48.45%32.67M36.84%32.22M
Operating profit 74.73%-22.14M81.15%-4.57M120.52%2.6M79.41%-4.99M42.64%-15.18M19.74%-87.61M25.67%-24.22M49.56%-12.68M0.17%-24.23M2.50%-26.47M
Net non-operating interest income expense -220.23%-1.66M52.53%-178K-203.42%-355K-569.88%-556K-1,123.21%-573K62.12%-519K-276.89%-375K-124.02%-117K16.16%-83K102.84%56K
Non-operating interest income -7.72%12.73M6.74%3.42M-6.28%3.25M-12.99%3.03M-16.79%3.02M0.41%13.79M-15.13%3.2M-14.58%3.47M-3.89%3.49M59.90%3.63M
Non-operating interest expense 0.55%14.39M0.53%3.6M0.56%3.61M0.56%3.59M0.53%3.6M-5.26%14.31M0.45%3.58M0.34%3.59M-4.21%3.57M-15.68%3.58M
Other net income (expense) 95.47%2.37M-194.37%-218K136.34%395K-72.44%86K19.98%2.11M102.34%1.21M107.55%231K-182.22%-1.09M100.63%312K316.65%1.76M
Special income (charges) --0------------------0--0--0--0----
Other non- operating income (expenses) 95.47%2.37M-194.37%-218K136.34%395K-72.44%86K19.98%2.11M142.95%1.21M107.55%231K-182.22%-1.09M213.87%312K316.65%1.76M
Income before tax 75.35%-21.43M79.63%-4.96M119.03%2.64M77.26%-5.46M44.64%-13.65M46.49%-86.91M31.24%-24.37M40.49%-13.89M67.44%-24M17.62%-24.66M
Income tax 87.96%1.94M233.16%767K-175.50%-262K-36.69%402K64.90%1.03M3.94%1.03M-356.00%-576K39.36%347K100.95%635K210.45%624K
Net income 73.43%-23.36M75.91%-5.73M120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M
Net income continuous Operations 73.43%-23.36M75.91%-5.73M120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M
Minority interest income
Net income attributable to the parent company 73.43%-23.36M75.91%-5.73M120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 73.43%-23.36M75.91%-5.73M120.41%2.91M76.21%-5.86M41.94%-14.68M46.18%-87.94M33.28%-23.79M39.65%-14.24M66.72%-24.64M16.10%-25.28M
Basic earnings per share 74.59%-0.4777.57%-0.1104120.00%0.0676.92%-0.1244.44%-0.353.75%-1.8530.63%-0.492247.37%-0.373.20%-0.5232.50%-0.54
Diluted earnings per share 74.59%-0.4777.57%-0.1104116.67%0.0576.92%-0.1244.44%-0.353.75%-1.8530.63%-0.492247.37%-0.373.20%-0.5232.50%-0.54
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More